Search research articles
Contact Us
Filters
Showing results (51-60 of 186) with videos related to
Page
of 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2008
Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry
Bruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
Case Reports in Oncology
|
August 26, 2010
Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer
Mohammad Mobayed, Lance K Heilbrun, Anthony F Shields, et al.
Molecular Imaging and Biology
|
October 11, 2003
High 2-deoxy-2-[18F]fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor
Subhash Chander, Eser Lay Ergun, Harry T Chugani, et al.
Investigational New Drugs
|
August 29, 2006
Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma
Ulka N Vaishampayan, Lance K Heilbrun, Anthony F Shields, et al.
Journal of Gastrointestinal Oncology
|
January 18, 2020
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers
Kabir Mody, Jason Starr, Michelle Saul, et al.
American Journal of Clinical Oncology
|
January 3, 2019
Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer Center
Kevin J Zhang, Greg Dyson, Joshua L Gatz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2017
Intended Versus Inferred Treatment After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Bruce E Hillner, Lucy Hanna, Rajesh Makineni, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 23, 2010
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
Nazik Hammad, Lance K Heilbrun, Philip A Philip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2012
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts
Bruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2017
Hospice Admission and Survival After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F Gareen, Bruce E Hillner, Lucy Hanna, et al.
Page
of 19
Search research articles
Search
Showing results (51-60 of 186) with videos related to
Sort By:
Page
of 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 11, 2008
Relationship between cancer type and impact of PET and PET/CT on intended management: findings of the national oncologic PET registry
Bruce E Hillner, Barry A Siegel, Anthony F Shields, et al.
Case Reports in Oncology
|
August 26, 2010
Safety and Feasibility of Carboplatin and Paclitaxel followed by Fluoropyrimidine Analogs and Radiation as Adjuvant Therapy for Gastric Cancer
Mohammad Mobayed, Lance K Heilbrun, Anthony F Shields, et al.
Molecular Imaging and Biology
|
October 11, 2003
High 2-deoxy-2-[18F]fluoro-D-glucose accumulation in a case of retroperitoneal fibrosis following resection of carcinoid tumor
Subhash Chander, Eser Lay Ergun, Harry T Chugani, et al.
Investigational New Drugs
|
August 29, 2006
Phase II trial of interferon and thalidomide in metastatic renal cell carcinoma
Ulka N Vaishampayan, Lance K Heilbrun, Anthony F Shields, et al.
Journal of Gastrointestinal Oncology
|
January 18, 2020
Patterns and genomic correlates of PD-L1 expression in patients with biliary tract cancers
Kabir Mody, Jason Starr, Michelle Saul, et al.
American Journal of Clinical Oncology
|
January 3, 2019
Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma With the Introduction of New Chemotherapeutic Drugs: 10-Year Experience of a Single NCI-designated Comprehensive Cancer Center
Kevin J Zhang, Greg Dyson, Joshua L Gatz, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 2, 2017
Intended Versus Inferred Treatment After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Bruce E Hillner, Lucy Hanna, Rajesh Makineni, et al.
Asia-Pacific Journal of Clinical Oncology
|
June 23, 2010
CA19-9 as a predictor of tumor response and survival in patients with advanced pancreatic cancer treated with gemcitabine based chemotherapy
Nazik Hammad, Lance K Heilbrun, Philip A Philip, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 27, 2012
Impact of 18F-FDG PET used after initial treatment of cancer: comparison of the National Oncologic PET Registry 2006 and 2009 cohorts
Bruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 30, 2017
Hospice Admission and Survival After <sup>18</sup>F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry
Ilana F Gareen, Bruce E Hillner, Lucy Hanna, et al.
Page
of 19